Back
Goldman Sachs Nasdaq-100 Core Prm IncETF Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
55
GPIQ
Goldman Sachs Nasdaq-100 Core Prm IncETF
Last Price:
47.62
Seasonality Move:
17.24%
Buy
82
MDGL
Madrigal Pharmaceuticals
Last Price:
320.26
Seasonality Move:
31.67%
Buy
55
Goldman Sachs Nasdaq-100 Core Prm IncETF (GPIQ)
is a Buy
Is Goldman Sachs Nasdaq-100 Core Prm IncETF a Buy, Sell or Hold?
- The current Goldman Sachs Nasdaq-100 Core Prm IncETF [GPIQ] share price is $47.66. The Score for GPIQ is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- GPIQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
82
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $319.58. The Score for MDGL is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
GPIQ Stock Price Chart
What is Goldman Sachs Nasdaq-100 Core Prm IncETF's stock price today?
-
The Goldman Sachs Nasdaq-100 Core Prm IncETF share price today is $47.66
The current trend is moderately bearish and GPIQ is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $319.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPIQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 45.1 | Sell |
| Chaikin Money Flow: | -5229 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.38 - 48.24) | Sell |
| Bollinger Bands (100): | (45.83 - 48.45) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.37 | Buy |
| Relative Strength Index (14 RSI): | 85.5 | Buy |
| Chaikin Money Flow: | 2945933 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (194.64 - 241.02) | Buy |
| Bollinger Bands (100): | (221.59 - 279.03) | Buy |
GPIQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48 | Sell |
| 20-day SMA: | 47.93 | Sell |
| 50-day SMA: | 47.2 | Buy |
| 200-day SMA: | 46.45 | Buy |
| 8-day EMA: | 47.93 | Sell |
| 20-day EMA: | 47.85 | Sell |
| 50-day EMA: | 47.42 | Buy |
| 200-day EMA: | 46.08 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 230.72 | Buy |
| 20-day SMA: | 219.8 | Buy |
| 50-day SMA: | 228.31 | Buy |
| 200-day SMA: | 241.11 | Buy |
| 8-day EMA: | 244.62 | Buy |
| 20-day EMA: | 228.06 | Buy |
| 50-day EMA: | 230.04 | Buy |
| 200-day EMA: | 234.49 | Buy |
Goldman Sachs Nasdaq-100 Core Prm IncETF Earnings Growth & GPIQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $3.75 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.12 per share, and an increase next year of $8.67 per share.
Goldman Sachs Nasdaq-100 Core Prm IncETF Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||